Dermatology pharmacology and prescribing Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

what makes a medication liscenced?

A

Approved for use in UK either by
MHRA – Medicines and Healthcare Products Regulatory Agency
EMA – European Medicines Agency
High standards of safety and quality
Trial evidence to show positive effect
SMC submission
Scottish Medicines Consortium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

when is medication not liscenced?

A

Unlicensed
Not approved for use in the UK
‘Off label’
A licensed medication that is being used for an unlicensed indication
‘Specials’
unlicensed dermatological preparations
Long history of use, no strong evidence base but clinically effective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are causes of prescription errors?

A

Lack of knowledge
About the patient, the medication, allergies
Mistake writing/generating the prescription
Poor communication
No local or national guidelines

Pharmacy/medicine info service

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what factors are associated with poor adherence?

A

Psychiatric co-morbidities
Slower acting agents
Multiple applications per day
Lack of patient education
Cosmetic acceptability of treatments
Unintentional non-adherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is pharmacokinetics?

A

The effect of the body on the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is pharmacodynamics?

A

The effect of the drug on the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what needs to be thought about in terms of pharmacokinetics?

A

Need to think about route of administration
topically where possible
If oral, optimal absorption important

Distribution – where the drug goes
Metabolism – especially in liver disease
Excretion – especially in renal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what needs to be thought about in terms of pharmacodynamics?

A

Individual variation in response
Think about
Age of patient
Pregnancy risk
Drug interactions
Pharmacogenetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is topical therapy?

A

Medication applied to the skin
Vehicle + active drug

Vehicle: pharmacologically inert, physically and chemically stable substance that carries the active drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what factors effect topical absorption?

A

Concentration
Base/vehicle
Chemical properties of the drug
Thickness and hydration of stratum corneum
Temperature
Skin site
Occlusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are examples of drugs that are used topically?

A

Corticosteroid Chemotherapy
Antibiotic Parasiticidals
Antiviral Coal Tar
Dithranol Anti-inflammatory
Vitamin analogues Salicylic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are topical steroids?

A

Anti- inflammatory and immunosuppressive properties
Regulate pro inflammatory cytokines
Suppress fibroblast, endothelial, and leukocyte function
Vasoconstriction
Inhibit vascular permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what do topical steroids do?

A

Regulate pro inflammatory cytokines
Suppress fibroblast, endothelial, and leukocyte function
Vasoconstriction
Inhibit vascular permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how are units of topical steroids measured for children especially?

A

About 0.5 g

Should treat area double the size of one hand

Useful in young children

Charts available for age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are side effects of topical steroids?

A

Thinning /atrophy
Striae
Bruising
Hirsutism
Telangiectasia
Acne/rosacea/perioral dermatitis
Glaucoma
Systemic absorption
Cataracts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are systemic treatments in dermatology?

A

Retinoids
Traditional immunosuppressants
Biologics (also immunosuppressive)

17
Q

what are retinoids?

A

Vitamin A analogues
Normalise keratinocyte function
Anti inflammatory and anti cancer effects
Four different molecules used orally in dermatology

18
Q

when is use of retinoids effective?

A

Acne isotretinoin
Psoriasis acitretin
Cutaneous T cell lymphoma bexarotene
Hand eczema alitretinoin

19
Q

can retinoids be used in pregnant patients?

A

Careful patient selection

20
Q

what are side effects of retinoids?

A

Cheilitis(dry lips) and xerosis (dry skin)
↑transaminases, ↑triglycerides
Rarely psychiatric, eye, bone side effects

21
Q

what are immunosuppressants?

A

Treatment of inflammatory skin disorders

Oral steroids
Azathioprine
Ciclosporin
Methotrexate
Mycophenolate mofetil

22
Q

what risks are associated with immunosuppressants?

A

Risk of malignancy and serious infection

Need regular blood test monitoring, in particular
FBC (esp in methotrexate and azathioprine)
Renal function (esp ciclosporin)
Liver function (esp methotrexate)

23
Q

what are biologics?

A

The next generation in treatment of inflammatory conditions
Genetically engineered proteins derived from human genes
designed to inhibit specific components of the immune system
Very effective, but expensive

24
Q

how are biologics named?

A

A series of infixes which immediately precede –mab:
zu humanised
ix chimeric
u fully human
li-/-l- immunomodulator
E.g.adalimumab = immunomodulator fully human monoclonal antibodies
Infliximab = immunomodulator chimeric monoclonal antibodies

25
Q

Current licensed biologics for dermatology conditions?

A

Psoriasis – nine
Hidradenitis suppurativa – one
Chronic spontaneous urticaria – one
Atopic eczema – one
Pemphigus – one

26
Q

what risks are associated with biologics?

A

Risk of infection
TB reactivation
Serious infection
Avoid live vaccines
Risk of malignancy
TNF inhibitors – risk of demyelination

27
Q

what targeted treatments are used for melanoma?

A

A revolution in treatment options for advanced melanoma
Targeted treatment for stage 4 disease
Adjuvant use in stage 3 disease

Targeted treatment
If BRAF 600 mutation
Vemurafenib
Dabrafenib
Immunotherapies
Ipilumumab
Pembrolizumab

28
Q
A